ArticleThe lancet. HIV2025

The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.

Emily P Hyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.